
QuidelOrtho Corporation
- Jurisdiction
United States - ISIN
US2197981051 (QDEL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. Read full profile
Stock price
Fundamentals
- Net revenue
€2.34B - Gross margin
56.6% - EBIT
-€45.46M - EBIT margin
-1.9% - Net income
-€376.49M - Net margin
-16.1%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 8, 2024